MS SB2145 | 2024 | Regular Session
Status
Completed Legislative Action
Spectrum: Partisan Bill (Republican 8-0)
Status: Failed on April 2 2024 - 100% progression
Action: 2024-04-02 - Died In Committee
Text: Latest bill text (Engrossed) [HTML]
Spectrum: Partisan Bill (Republican 8-0)
Status: Failed on April 2 2024 - 100% progression
Action: 2024-04-02 - Died In Committee
Text: Latest bill text (Engrossed) [HTML]
Summary
An Act To Be Known As The Defending Affordable Prescription Drug Costs Act; To Provide Definitions For The Purpose Of The Act; To Prohibit Health Insurance Issuers, Pharmacy Benefit Managers And Other Third-party Payors And Drug Manufacturers And Distributors From Engaging In Certain Discriminatory Actions Relating To Entities That Are Participating Or Authorized To Participate In The Federal 340b Drug Discount Program; To Provide That The Commission Of Any Act Prohibited By This Act Is Considered A Violation Of The Consumer Protection Act; To Amend Section 75-24-5, Mississippi Code Of 1972, To Conform To The Preceding Provision; And For Related Purposes.
Title
Defending Affordable Prescription Drug Costs Act; enact to prohibit discriminating against 340B drug discount program entities.
Sponsors
| Sen. Brice Wiggins [R] | Sen. Kevin Blackwell [R] | Sen. Nicole Boyd [R] | Sen. Jeremy England [R] |
| Sen. Mike Thompson [R] | Sen. Joel Carter [R] | Sen. David Parker [R] | Sen. Dennis DeBar [R] |
Roll Calls
2024-03-12 - Senate - Senate Passed (Y: 52 N: 0 NV: 0 Abs: 0) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2024-04-02 | House | Died In Committee |
| 2024-03-18 | House | Referred To Drug Policy;Public Health and Human Services |
| 2024-03-13 | Senate | Transmitted To House |
| 2024-03-12 | Senate | Passed |
| 2024-02-28 | Senate | Title Suff Do Pass |
| 2024-02-02 | Senate | Referred To Public Health and Welfare |
